TIA Clinical Trials

1,124 recruitingLast updated: July 25, 2026

There are 1,124 actively recruiting tia clinical trials across 70 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


TIA Trials at a Glance

1,124 actively recruiting trials for tia are listed on ClinicalTrialsFinder across 6 cities in 70 countries. The largest study group is Not Applicable with 401 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running tia studies include Assistance Publique - Hôpitaux de Paris, Massachusetts General Hospital, and National Cancer Institute (NCI).

Treatments under study

About TIA Clinical Trials

Looking for clinical trials for TIA? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new TIA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about TIA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,124 trials

Recruiting
Phase 2

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.180 enrolled59 locationsNCT07029581
Recruiting
Phase 3

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more
National Cancer Institute (NCI)360 enrolled409 locationsNCT05256225
Recruiting
Not Applicable

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

DementiaDiabetesHypoglycemia+1 more
Indiana University62 enrolled1 locationNCT05643144
Recruiting
Phase 3

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

allogeneic stem cell transplantationCardiovascular DiseasesAcute Lung Injury+3 more
National Heart, Lung, and Blood Institute (NHLBI)210 enrolled1 locationNCT07613099
Recruiting
Phase 2

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled5 locationsNCT06458036
Recruiting

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Amyotrophic Lateral SclerosisFrontotemporal DementiaProgressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS)360 enrolled1 locationNCT03225144
Recruiting
Early Phase 1

A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

First in Man Study to Evaluate Initial SafetyOverweight and Obese AdultsHealthy Participants Study
Zealand Pharma88 enrolled1 locationNCT07721597
Recruiting
Not Applicable

Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery

StrokeStroke (CVA) or TIACerebral Vascular Accident (CVA)/Stroke
Ohio State University12 enrolled1 locationNCT07723300
Recruiting
Not Applicable

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

Interstitial Lung DiseasePulmonary Hypertension
University of Rochester30 enrolled1 locationNCT07561034
Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc.320 enrolled70 locationsNCT06651567
Recruiting
Phase 2

Testing the Pain Clinical Practice Guideline

PainDementia
University of Maryland, Baltimore300 enrolled11 locationsNCT05858996
Recruiting
Not Applicable

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

Chronic Obstructive Pulmonary DiseaseInterstitial Lung DiseaseHypoxemia
State University of New York at Buffalo24 enrolled1 locationNCT07512687
Recruiting

Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions

Cognitive ImpairmentDementiaDelirium
Universitätsklinikum Hamburg-Eppendorf404 enrolled1 locationNCT07114458
Recruiting
Phase 4

SGLT2i Therapy in Islet Transplantation (SIT)

DiabetesPartial Islet FunctionTPIAT
University of Minnesota40 enrolled1 locationNCT07228195
Recruiting

Childhood-Onset Essential Hypertension Natural History Study

HypertensionEssential Hypertension
National Human Genome Research Institute (NHGRI)2,300 enrolled1 locationNCT06778239
Recruiting
Phase 3

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer Disease Dementia
University College, London1,200 enrolled2 locationsNCT07724132
Recruiting
Not Applicable

Motor Network Physiology

Parkinson DiseaseEssential Tremor
University of Texas Southwestern Medical Center120 enrolled1 locationNCT04957095
Recruiting

Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers

Alzheimer DiseaseVascular DementiaMild Cognitive Disorder+2 more
University of Erlangen-Nürnberg Medical School5,000 enrolled12 locationsNCT07721701
Recruiting

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis (RA)Rheumatoid Arthritis-Associated Interstitial Lung DiseaseDifficult-to-Treat Rheumatoid Arthritis
Dongyi He10,000 enrolled1 locationNCT07484243
Recruiting
Phase 4

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

MalnutritionMalnutrition, ChildEssential Fatty Acid Deficiency (EFAD)+1 more
Fresenius Kabi100 enrolled5 locationsNCT06049680